Day: September 2, 2021

WINNIPEG, Manitoba, Sept. 02, 2021 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF), (the “Company” or “Kane Biotech”), today announces that it has entered into an amended and restated credit agreement with Pivot Financial Inc. (“Pivot”) dated August 31, 2021 (the “Amended Credit Facility”). The Amended Credit Facility amends and restates the existing credit agreement with Pivot dated November 5, 2020, increasing the credit facility to $2.5 million from $1.48 million. The Amended Credit Facility shall continue to be used by Kane Biotech for: (i) funding research and development relating to eligible government reimbursable expenditures; (ii) expenses related to STEM Animal Health Inc; and (iii) general working capital purposes. “This new facility provides Kane Biotech with the access to additional working capital that...

BOSTON, Sept. 02, 2021 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic diseases of obesity, today announced that David Meeker, M.D., Chair, President and Chief Executive Officer, will participate in a fireside chat at the Morgan Stanley 19th Annual Global Healthcare Conference on Thursday, September 9, 2021 at 8:45 a.m. ET. A live webcast of the presentation will be available under “Events & Presentations” in the Investor Relations section of the Company’s website at www.rhythmtx.com. A replay of the webcast will be available on the Rhythm website for 30 days following the presentation. About Rhythm PharmaceuticalsRhythm is a commercial-stage biopharmaceutical company committed to transforming the...

REHOVOT, Israel and WILMINGTON, Del., Sept. 02, 2021 (GLOBE NEWSWIRE) — Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA), a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers, today announced that Ayala management will participate in two upcoming virtual investor conferences in September:H.C. Wainwright 23rd Annual Global Investor Conference: Corporate Presentation available on-demand starting Monday, September 13, 2021 at 7:00 am ET. Citi’s 16th Annual Biopharma Virtual Conference: Management will participate in investor meetings on Thursday, September 9, 2021.A webcast of the H.C. Wainwright 23rd Annual Global Investor Conference presentation may be accessed by visiting the Events & Presentations section of Ayala’s website...

PHILADELPHIA, Sept. 02, 2021 (GLOBE NEWSWIRE) — Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases, today announced that the Company will participate in two upcoming investor conferences in September:Morgan Stanley 19th Annual Global Healthcare Conference: Steven Nichtberger, M.D., President and Chief Executive Officer, will participate in a fireside chat on Thursday, September 9, 2021 at 1:15 p.m. ET. Members of management will also be available for one-on-one meetings.H.C. Wainwright 23rd Annual Global Investment Conference: Steven Nichtberger, M.D., President and Chief Executive Officer, will participate in a pre-recorded fireside chat, which will become available for on-demand...

REDWOOD CITY, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) — Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biotechnology company pioneering a new class of immuno-oncology agents that combine the targeting precision of antibodies with the power of both the innate and adaptive immune systems, today announced that management will present a corporate update and conduct meetings with the investment community at four upcoming virtual investor conferences in September:Citi’s 16th Annual BioPharma Virtual ConferenceMeetings with investors on Wednesday, Sept. 8Wells Fargo Virtual Healthcare ConferencePresentation on Thursday, Sept. 9, at 12:30 p.m. PT (3:20 p.m. ET)Morgan Stanley 19th Annual Global Healthcare ConferenceFireside chat on Monday, Sept. 13, at 12:30 p.m. PT (3:30 p.m. ET)2021 Cantor Fitzgerald Virtual Global Healthcare...

NORTH BILLERICA, Mass., Sept. 02, 2021 (GLOBE NEWSWIRE) — Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider committed to innovative imaging diagnostics, targeted therapeutics and artificial intelligence solutions to find, fight and follow serious medical conditions, today announced Mary Anne Heino, President and Chief Executive Officer, and Bob Marshall, Chief Financial Officer and Treasurer, will present at the following investor conferences.Wells Fargo 2021 Virtual Healthcare ConferenceSeptember 9, 2021 at 4 p.m. ETBaird 2021 Global Healthcare ConferenceSeptember 15, 2021 at 7:55 a.m. ETTo access a live webcast of the presentation, please visit the Investors section of the Company’s website at www.lantheus.com. A replay of the webcast will be available on the Company’s...

IRVINE, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) — Advantage Solutions Inc. (NASDAQ: ADV) (“Advantage,” the “Company,” “we” or “our”), the leading provider of outsourced sales and marketing services to consumer goods companies and retailers, today announced that its management team will attend the Barclays Global Consumer Staples Conference on September 10, 2021. Investors who are interested in setting up a meeting may contact Advantage Investor Relations or their Barclays conference representative. About Advantage Solutions Advantage Solutions is a leading business solutions provider committed to driving growth for consumer goods manufacturers and retailers through winning insights and execution. Advantage’s data and technology-enabled omnichannel solutions — including sales, retail merchandising, business intelligence, digital...

CRANBURY, N.J., Sept. 02, 2021 (GLOBE NEWSWIRE) — PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutants, today announced that David H. Mack, Ph.D., President & Chief Executive Officer, will present at the Morgan Stanley 19th Annual Global Healthcare Conference taking place September 9-10 and 13-15, 2021. The company will also participate in one-on-one investor meetings at the conference. Details on the presentation can be found below.Morgan Stanley 19th Annual Global Healthcare ConferenceDate: Thursday, September 9th, 2021Time: 4:15pm ETAbout PMV Pharma PMV Pharma is a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting...

Virtual event will highlight the broad potential of the Cloudbreak® platform and the commercial potential for rezafungin Clinical thought leaders will highlight the risks of invasive fungal infections in cancer patients, and the unmet medical need in respiratory viral diseases Webinar to be held on Tuesday, September 21st at 10:00am ET SAN DIEGO, Sept. 02, 2021 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology company developing long-acting compounds designed to transform the standard of care for prevention and treatment of serious diseases, today announced that it will host a research and development day webinar on Tuesday, September 21, 2021 from 10am to 12pm Eastern Time. The webinar will feature presentations by clinical thought leaders Mark James Levis, M.D., Ph.D., and Kieren Marr, M.D., both from...

CAMBRIDGE, Mass., Sept. 02, 2021 (GLOBE NEWSWIRE) — Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, today announced that company management will participate at several upcoming investor conferences in September:2021 Wells Fargo Virtual Healthcare Conference: Fireside chat on Friday September 10, 2021 at 8:00 a.m. ET. H.C. Wainwright 23rd Annual Global Investment Conference: Presentation will be available on-demand during the conference, starting on Monday, September 13, 2021 at 7:00 a.m. ET. Baird’s 2021 Global Healthcare Conference: Presentation on Wednesday, September 15, 2021 at 12:15 p.m. ET.  2021 Cantor Fitzgerald Virtual Global Healthcare Conference: Presentation on Wednesday, September 29, 2021 at 4:00...